PROGRESS IN THE CLINICAL USE OF 3-(ORTHO-TOLOXY)-1, 2-PROPANEDIOL (MEPHENESIN) IN NEUROLOGIC DISORDERS

[1] BALLANTINE ROBERT I. W., 1948, ANAESTHESIA, V3, P20, DOI 10.1111/j.1365-2044.1948.tb02107.x

[2] THE MODE OF ACTION OF MYANESIN [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1947, 2 (04): : 241 - 250

[3] THE PHARMACOLOGICAL PROPERTIES OF ALPHA-BETA DIHYDROXY-GAMMA-(2-METHYLPHENOXY)-PROPANE (MYANESIN) [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1946, 1 (04): : 265 - 272

[4] BERGER FM, 1948, J PHARMACOL EXP THER, V93, P362

[5] BERGER FM, 1947, Q J PHARM PHARMACOL, V20, P94

[6] BERGER FM, 1947, LANCET, V252, P97

[7] ORAL MYANESIN IN TREATMENT OF SPASTIC AND HYPERKINETIC DISORDERS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1948, 137 (09): : 772 - 774

[8] BERGER FM, 1948, J PHARMACOL EXP THER, V93, P470

[9] MUSCLE-RELAXING ETHERS OF GLYCEROL [J]. NATURE, 1947, 159 (4050) : 813 - 814

[10] BROOKS DM, 1948, LANCET, V254, P306

[1] BALLANTINE ROBERT I. W., 1948, ANAESTHESIA, V3, P20, DOI 10.1111/j.1365-2044.1948.tb02107.x

[2] THE MODE OF ACTION OF MYANESIN [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1947, 2 (04): : 241 - 250

[3] THE PHARMACOLOGICAL PROPERTIES OF ALPHA-BETA DIHYDROXY-GAMMA-(2-METHYLPHENOXY)-PROPANE (MYANESIN) [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1946, 1 (04): : 265 - 272

[4] BERGER FM, 1948, J PHARMACOL EXP THER, V93, P362

[5] BERGER FM, 1947, Q J PHARM PHARMACOL, V20, P94

[6] BERGER FM, 1947, LANCET, V252, P97

[7] ORAL MYANESIN IN TREATMENT OF SPASTIC AND HYPERKINETIC DISORDERS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1948, 137 (09): : 772 - 774

[8] BERGER FM, 1948, J PHARMACOL EXP THER, V93, P470

[9] MUSCLE-RELAXING ETHERS OF GLYCEROL [J]. NATURE, 1947, 159 (4050) : 813 - 814

[10] BROOKS DM, 1948, LANCET, V254, P306